Up to half of MPNST cases are diagnosed in people with the NF1 disease [7], and 41% of the remaining sporadic MPNST cases present with sporadic mutations in the Nf1 gene [8], highlighting the role of Nf1-mediated deregulation in the biogenesis of MPNSTs. Here, NF1 is linked to malignant peripheral nerve sheath tumor.